Upon recommendation of the Nominating and Governance Committee of the Board of Directors of Bionano Genomics, Inc. (the Company), on February 17, 2022, the Board appointed Aleksandar Rajkovic as a Class III director, effective as of such date, to serve in such capacity until the Company's 2024 annual meeting of stockholders. Dr. Rajkovic will receive compensation for his service as a director in accordance with the Company's Non-Employee Director Compensation Policy, as amended (the Compensation Policy).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8351 USD | -2.76% | -8.89% | -55.81% |
05-28 | Bionano Genomics Raises $18 Million From Private Debentures Placement | MT |
05-24 | Bionano Genomics, Inc. announced that it has received $18 million in funding | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-55.81% | 59.07M | |
+8.46% | 220B | |
+14.38% | 194B | |
+26.90% | 149B | |
+33.90% | 113B | |
+4.45% | 65.75B | |
+15.11% | 52.43B | |
+1.93% | 50.47B | |
-4.22% | 38.54B | |
-1.75% | 34.12B |
- Stock Market
- Equities
- BNGO Stock
- News Bionano Genomics, Inc.
- Bionano Genomics, Inc. Appoints Aleksandar Rajkovic as Class III Director